Global Automated Biochemical Analyzers Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Automated Biochemical Analyzers Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Automatic biochemistry analyzer could be a high-performance micro-controller based mostly measurement organic chemistry instrument used to live varied blood organic chemistry parameters like glucose, urea, protein, and bilirubin etc. that are related to varied disorders like diabetes, kidney diseases, liver malfunctions and alternative metabolic derangements.

Market Overview:

The latest research study on the global Automated Biochemical Analyzers market finds that the global Automated Biochemical Analyzers market reached a value of USD 3661.38 million in 2022. It’s expected that the market will achieve USD 5064.32 million by 2028, exhibiting a CAGR of 5.56% during the forecast period.

The role of automated biochemical analysis for COVID-19

Automated biochemical analyzers vastly accelerate the testing of patient samples in laboratories, which has become critical now that the COVID-19 pandemic has spread across the globe. Advanced automation with motor-based motion systems will help in the fight to hasten diagnosis. Just consider the cobas 6800 and 8800 machines from Roche that automate testing of nasopharyngeal and oropharyngeal swab samples from patients suspected of having COVID-19. On March 13, 2020, the FDA issued Emergency Use Authorization for their SARS-CoV-2 tests run on cobas automated systems. This will make large-scale testing faster and more efficient.

Insufficient raw materials

Due to the impact of COVID-19, market transportation has been restricted and trade liquidity has weakened, resulting in a large shortage of medical raw materials and equipment resources. At the beginning of the epidemic, the market stock was not high, the overall supply was tight, and prices rose in various places. Due to insufficient raw materials, prices will rise. In general, the market for the current automated biochemical analyzers will be in short supply, and manufacturers are reluctant to conduct low-price transactions. Despite sluggish demand, overall trading downside is relatively limited.

Increase in geriatric population will boost the adoption of automated biochemical analyzers

The growth in the aging population worldwide will boost the demand for automated biochemical analyzers. Automated biochemical analyzers are increasingly being used in the determination of the health condition of a person by analyzing body fluid samples like blood and urine. In addition, the rising number of age-related ailments such as kidney, liver, and heart will contribute to the growth of the automated biochemical analyzers market. The increased preference for preventive healthcare has boosted the demand for early detection and treatment of age-related health conditions, which in turn, will augment the growth of automated biochemical analyzers market in the forecast period.

Market competition is getting fiercer

The automated biochemical analyzer industry market is becoming more and more fragmented, and there are many suppliers offering products that can determine a person's health by analyzing blood and urine samples. Large and mature suppliers of automatic biochemical analyzers are working to develop advanced hematology analyzers to meet the needs of healthcare centers and research institutions. Many international and regional suppliers are vying for their market share, and participants must be different in order to win important appeal to competitors. This factor will limit the development of small automated biochemical analyzer manufacturers.

Region Overview:

From 2022-2027, Europe is estimated to witness robust growth prospects.

Company Overview:

Roche is one of the major players operating in the Automated Biochemical Analyzers market, holding a share of 22.57% in 2020.

Roche

Roche develops and manufactures pharmaceutical and diagnostic products. The Company produces prescription drugs in the areas of cardiovascular, infectious, autoimmune, respiratory diseases, dermatology, metabolic disorders, oncology, transplantation, and the central nervous system.

Siemens Healthcare

Siemens Healthcare provides clinical diagnostic services and therapeutic systems. The Company's health services include blood gas monitoring, molecular testing systems, hematology, microbiology, and other medical services. Siemens Healthcare also offers data management solutions for the prevention, detection, diagnosis, and therapy of medical illnesses.

Segmentation Overview:

By type, Floor-standing segment accounted for the largest share of market in 2021.

Floor-standing

The floor-standing automated biochemical analyzer is a fully automatic device with a direct reading system and random operating channels. It has an automatic cleaning station for samples and reagent probes. Provide liquid level detection, provide anti-collision protection for samples and reagent probes. The reagent chamber has a built-in cooling system.

Bench-top

The bench-top automated biochemical analyzer is a compact instrument that can achieve maximum efficiency. The bench-top automated biochemical analyzer is easy to use and greatly reduces the daily workload. It is the perfect solution for small laboratories to bridge the gap from manual to automated.

Application Overview:

By application, the Prefectural Hospital segment occupied the biggest share from 2017 to 2022.

Primary Hospital

Primary hospitals are usually township health centers with less than 100 beds. Their mission is to provide preventive health care, minimal medical care and rehabilitation services. Because of funding and site issues, the primary hospitals need relatively few automated biochemical analyzers.

Prefectural Hospital

Prefectural hospitals usually contain more than 100 beds, but less than 500. They are responsible for providing comprehensive medical services, as well as medical and educational research areas.

Provincial Hospital

The provincial hospital is usually a comprehensive, referral, in the city general hospital, the capacity of one bed exceeds 500 at the provincial level. They are responsible for providing professional medical services, medical education and scientific research that play a greater role in the implementation.

Key Companies in the global Automated Biochemical Analyzers market covered in Chapter 3:

Mindray Medical
Siemens Healthcare
Beckman Coulter (Danaher)
Adaltis
Abbott Laboratories
Rayto Life and Analytical Sciences
ELITech
Hitachi
Roche
KHB
Horiba Medical
Hologic
Thermo Scientific
Randox Laboratories
Abaxis

In Chapter 4 and Chapter 14.2, on the basis of types, the Automated Biochemical Analyzers market from 2018 to 2029 is primarily split into:

Floor-standing
Bench-top

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Automated Biochemical Analyzers market from 2018 to 2029 covers:

Primary Hospital
Prefectural Hospital
Provincial Hospital

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)